CPHI Barcelona 2023 – Event preview
CPHI Barcelona takes place in October 2023, covering a wide range of topics from next generation biomanufacturing and formulation to sustainability.
List view / Grid view
CPHI Barcelona takes place in October 2023, covering a wide range of topics from next generation biomanufacturing and formulation to sustainability.
9 June 2016 | By Victoria White, Digital Content Producer
The programme will enable patients with serious fungal infections in EU states where the treatment is not yet commercially available to access isavuconazole...
9 March 2016 | By Victoria White
Cresemba (isavuconazonium sulfate) is an azole antifungal indicated for patients 18 years of age and older for the treatment of invasive aspergillosis and invasive mucormycosis...
23 October 2015 | By Victoria White
Isavuconazole will benefit from ten years of market exclusivity associated with orphan medicinal product status in the European Union...
15 October 2015 | By Victoria White
Under the terms of the agreement, Hikma will have the exclusive rights to register, distribute and market Zevtera in all its Middle Eastern and North African markets...
27 July 2015 | By Victoria White
CHMP has adopted a positive opinion recommending the approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis...